Case File
efta-01456920DOJ Data Set 10OtherEFTA01456920
Date
Unknown
Source
DOJ Data Set 10
Reference
efta-01456920
Pages
1
Persons
0
Integrity
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
From:
Danya Friedman
on behalf of
AM:Compliance Inquiries ([email protected]
Sent:
3/4/2015 12:40:17 PM
To:
CC:
AMLCompliance Inquiries [email protected]
Subject:
Account U 35266976, Client: JEFFREY EPSTEIN, Alert # 5638111)
Importance:
High
Classification: For internal use only
Good Morning,
As a part of the PWM anti-money laundering monitoring program, the PRIME system is used to automatically identify
transactions that meet certain high risk transaction patterns. When transactions occur which mimic those patterns, the
activity must be researched to confirm that it is legitimate.
In a small percentage of these cases, Compliance must contact the Wealth Advisor for additional information about the
transaction(s) in order to conclude the research process. Your response is required for the Bank to comply with federal
guidelines for concluding the research of these matters in a timely fashion. Your complete response must be received
within 7 business days.
To the best of your ability, please provide details regarding the item(s) below:
ORIGINATOR: JEFFREY EPSTEIN
DOA: 09/18/2014 09/17/2014 and 09/22
4
AMT 125 000.00- 87 955.98-
$49,648.88
Wire To: CYPRESS INC ROLLS ROYCE PLC, and
1. What is the purpose of the outgoing wires?
d
i What is the relationship between Andrew J Bendheim and CYPRESS INC, ROLLS ROYCE PLC and
3. In what industry is CYPRESS INC and
involved?
Thank you in advance for your prompt attention to this matter.
Kind regards,
Danya B. Friedman
Danya B. Friedman
Intern AWIASNVM AML
DB Services New Jersey. Inc.
5022 Gate Parlmey. Suite 400, 32256 Jacksonville. USA
Tel. +1(904) 271-3358
Email clanya.MedmangOdb.com
Vet us: httIVINAMV,Clb.COM
Poun-ita,-*Peeftrost
PLEASE NOTE: YOU ARE BEING CONTACTED BECAUSE YOU ARE LISTED AS THE PRIMARY OFFICER FOR
THIS ACCOUNT ON GC/S. IF YOU ARE NOT THE CURRENT PRIMARY OFFICER, PLEASE LET ME KNOW
IMMEDIATELY, SO THAT I MAY FORWARD THIS EMAIL TO THE APPROPRIATE PARTY.
Do not forward this e-mail or any attachment directly to the
CONFIDENTIAL - PURSUANT TO FED. R. CRIM. P. 6(e)
DB-SDNY-0 116264
CONFIDENTIAL
SDNY_GM_00262448
EFTA01456920
Technical Artifacts (8)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Domain
clanya.medmangodb.comDomain
clb.comEmail
[email protected]Email
[email protected]Phone
+1(904) 271-3358Phone
5266976Phone
5638111SWIFT/BIC
IMMEDIATELYRelated Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.